Search results
Results From The WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Valeant Pharmaceuticals: Allergan, Inc: 45 58 Valeant Pharmaceuticals and activist investor Bill Ackman offered to buy Botox maker Allergan, proposing a cash-and-stock deal worth about $152.89. [31] 20 2014 Monsanto Company Inc. Syngenta AG: 40 51 Monsanto weighed $40 billion unsolicited bid for Swiss rival, Syngenta aiming to avoid US ...
This list comprises the world's largest companies by consolidated revenue, according to the Fortune Global 500 2024 rankings and other sources. [2] American retail corporation Walmart has been the world's largest company by revenue since 2014. [ 1 ]
List of Florida companies includes notable companies that are, or once were, headquartered in Florida. This is a dynamic list and may never be able to satisfy particular standards for completeness. You can help by adding missing items with reliable sources .
This is a complete list of multinational corporations, also known as multinational companies in worldwide or global enterprises. These are corporate organizations that own or control production of goods or services in two or more countries other than their home countries.
This list represents "best in class" companies from the ten economic sectors that make up the S&P 500. [11] In 2008, named to the World's Most Admired Companies list by Fortune. The company received the recognition again in 2010. In 2008, acquired RMBC, a provider of national pharmaceutical market intelligence and analytics in Russia.
The following five companies are Fortune 500 companies based in the metropolitan area: [3] (Ranking. Company Name (City) Annual Revenues) 126. Lennar , $34.2 billion 192. Office Depot , $12.1 billion 205. World Kinect Corporation (Miami), $11.3 billion 212. AutoNation (Fort Lauderdale), $11 billion 426. Ryder System (Miami), $5 billion
Two of the companies that had gotten approval to market generic versions of Maxzide, Vitarine Pharmaceutical and Par Pharmaceutical, were targets of the company's initial investigation and were found to have used Maxzide to obtain their bioequivalence data, leading both companies to withdraw its generic competitor to Mylan's product. [17] [29]